CD8: Definition



Print this article

CD8 is a protein found on the surface of certain immune cells. It is the main marker for cytotoxic T cells, which kill infected and cancerous cells. Pathologists test for CD8 in tissue to help classify T-cell lymphomas and to understand immune reactions. Pathologists usually test CD8 alongside CD4, which marks helper T cells.

This article explains what CD8 does, which cells carry it, how pathologists test for it, and what a CD8 result in a pathology report means.

What does CD8 do?

CD8 helps cytotoxic T cells find and destroy damaged cells. Cytotoxic T cells are a type of lymphocyte, a white blood cell. They patrol the body, checking other cells for signs of infection or cancer.

Every cell displays small pieces of the proteins it makes on its surface. CD8 helps the T cell grip the cell and read these pieces. If the pieces come from a virus or look abnormal, the T cell kills the cell. Some CD8-positive cells also become memory cells. These remember the threat and respond faster the next time.

Which cells carry CD8?

CD8 appears mainly on cytotoxic T cells. A few other cell types carry it too:

  • Cytotoxic T cells. These make up roughly a quarter to a third of the T cells in blood.
  • Natural killer (NK) cells. About a third of these immune cells carry CD8.
  • Cells lining the spleen. Special cells that line the blood channels of the spleen are also CD8-positive.

Pathologists usually look at CD8 together with CD3, which marks almost all T cells, and CD4, which marks helper T cells.

How do pathologists test for CD8?

Pathologists test for CD8 in tissue using immunohistochemistry. This test uses an antibody that sticks to CD8 in a thin slice of tissue. Cells that carry CD8 turn brown under the microscope.

Laboratories can also measure CD8 with flow cytometry. This test counts cells in a liquid sample, such as blood or bone marrow. Both methods are part of immunophenotyping, which sorts cells by the markers they carry.

Why do pathologists test for CD8?

Pathologists test for CD8 to learn what kinds of T cells are in a tissue sample. The result helps in several situations:

  • Classifying T-cell lymphomas. In some T-cell lymphomas, the cancer cells are mostly CD8-positive. In others, they are CD4-positive or carry neither marker. One example of a CD8-positive lymphoma is subcutaneous panniculitis-like T-cell lymphoma, which grows in the fat under the skin.
  • Mycosis fungoides. Mycosis fungoides is a lymphoma that starts in the skin. Most cases are CD4-positive. About 1 in 5 early cases are CD8-positive instead.
  • Telling lymphoma from inflammation. A normal immune reaction contains a mix of CD4-positive and CD8-positive T cells. A lymphoma often shows a large group of only one type. A reactive lymph node usually keeps the mix.
  • Specific types of inflammation. Some conditions shift the balance toward CD8-positive cells. One example is Kikuchi disease, a rare cause of swollen lymph nodes.

No single marker makes these diagnoses. The pathologist combines CD8 with the cells’ appearance and a panel of other markers.

What does a CD8 result mean in my report?

Your report may describe CD8 in several ways:

  • CD8 positive. The cells of interest carry CD8. In a lymphoma, this suggests the cells came from cytotoxic T cells.
  • CD8 negative. The cells of interest do not carry CD8. In a T-cell lymphoma, this often points toward a CD4-positive type.
  • CD4 to CD8 ratio. The report compares the numbers of CD4-positive and CD8-positive cells. A ratio far from the usual balance can support a lymphoma or a specific type of inflammation.
  • Mixed or reactive T cells. CD4-positive and CD8-positive cells appear in a normal-looking mix. This usually suggests a normal immune response.

A CD8-positive result does not mean cancer on its own. Healthy tissue and inflamed tissue contain many CD8-positive cells.

What are CD8-positive cells doing in a tumor?

Many tumors contain CD8-positive T cells. These are often the body’s own immune cells attacking the cancer. Pathologists may call them tumor-infiltrating lymphocytes. In this setting, the CD8-positive cells are not the cancer.

Their presence shows that the immune system has recognized the tumor. Research into how these cells affect outcomes and immunotherapy is ongoing. Your oncologist can tell you whether this applies to your cancer.

Questions to ask your doctor

  • Why did the pathologist test for CD8?
  • Were the abnormal cells CD8-positive or CD8-negative?
  • What was the balance of CD4-positive and CD8-positive cells?
  • Does this result suggest lymphoma or an ordinary immune reaction?
  • What other markers were part of the panel?
  • If I have lymphoma, which type does the CD8 result support?
  • Were CD8-positive immune cells seen inside my tumor, and does that matter?

Related articles on MyPathologyReport.com

A+ A A-
Was this article helpful?